A federal grand jury last week indicted Sanovas president & CEO Larry Gerrans on three counts of wire fraud and money laundering for alleged schemes to pay cash for a home and “myriad” personal expenses. Gerrans has denied the charges via a company spokesman. According to federal prosecutors and the FBI, Gerrans “employed a number of […]
Sanovas said yesterday it launched another subsidiary, SteriView, along with its SteriView instrument inspection and infection control system. The newly launched system is designed as a “front line solution” against hospital-acquired infections, Sausalito, Calif.-based Sanovas said. The system allows direct visual inspection and cleaning of hard to reach spaces on endoscopes and medical instruments. “Healthcare-acquired infections […]
Sanovas recently announced the launch of SinuGeniX, a wholly-owned subsidiary focused on treating chronic sinusitis with the company’s RegENT sinus treatment system. The newly-launched subsidiary won’t just supply a single tool for treating chronic sinusitis, which affects over 28 million Americans, but a suite of technologies, Sanovas CEO and system co-inventer Larry Gerrans told MassDevice.com in […]
Sanovas said last week that it won FDA 510(k) clearance for its PulmoVia working channel, part of its platform designed to improve diagnostic and therapeutic interventions in the lung. Working channels are normally integrated into bronchoscopes with optics as 1 piece, but the PulmoVia working channel is separate, CEO Larry Gerrans told MassDevice.com. “We took a […]
April 25, 2014 by Brian Johnson
Sanovas raised $6.5 million in a Series A1 round co-founder & CEO Larry Gerrans told MassDevice.com will go toward commercializing its Vas Zeppelin pulmonary device.
Sausalito, Calif.-based Sanovas closed a Series A round last summer consisting entirely of friends and family, Gerrans told us.
In talking about his company’s newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.
Sanovas said it’s asked the FDA for 510(k) clearance for its Vas Zeppelin Smart Catheter, designed to diagnose and treat chronic pulmonary conditions and lung cancer.
The Sausalito, Calif.-based medical device company bills the device as "among the smallest interventional catheters," saying it’s designed to "overcome the complexity and procedural risks associated with pulmonary intervention," according to a press release.
Most startup medical device companies raise 10s of millions to research and develop their products before they even get to the commercial stage. But for Sanovas and co-founder Larry Gerrans, the 12-year journey to that point required a scant $9 million – all raised from the pulmonary device firm’s founders, friends and family, Gerrans told MassDevice.com last month.